Astera Labs (ALAB) director-related trust sells 136,974 shares in plan trades

Rhea-AI Filing Summary

Astera Labs director-related trust reports pre-planned stock sales. Alba 2003 Living Trust, associated with director Manuel Alba, sold a total of 136,974 shares of Astera Labs common stock on July 1, 2026 in multiple open-market transactions under a pre-arranged Rule 10b5-1 trading plan.

The reported sale prices ranged from $429.11 to $459.44 per share, based on weighted-average pricing disclosures. Following these transactions, the trust continues to hold 1,418,661 shares of Astera Labs common stock indirectly for the benefit of the Alba 2003 Living Trust, with Manuel Alba-Marquez and his spouse as co-trustees, and Manuel Alba disclaiming beneficial ownership except to the extent of any pecuniary interest.

Insider Trade Summary 10b5-1

Net Seller: 136,974 shares ($60,543,455)

Net Sell 29 txns

Insider ALBA MANUEL

Role null

Sold 136,974 shs ($60.54M)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,837	$429.578	$2.51M
Sale	Common Stock	30,141	$430.7907	$12.98M
Sale	Common Stock	3,485	$432.7916	$1.51M
Sale	Common Stock	1,574	$433.4284	$682K
Sale	Common Stock	2,279	$434.7826	$991K
Sale	Common Stock	2,122	$435.7564	$925K
Sale	Common Stock	3,655	$436.8206	$1.60M
Sale	Common Stock	2,129	$437.9323	$932K
Sale	Common Stock	2,955	$438.7869	$1.30M
Sale	Common Stock	4,332	$440.0528	$1.91M
Sale	Common Stock	6,904	$440.8574	$3.04M
Sale	Common Stock	4,468	$441.7946	$1.97M
Sale	Common Stock	4,980	$442.8711	$2.21M
Sale	Common Stock	5,437	$443.8246	$2.41M
Sale	Common Stock	6,048	$444.9077	$2.69M
Sale	Common Stock	4,310	$445.8516	$1.92M
Sale	Common Stock	4,082	$446.9137	$1.82M
Sale	Common Stock	4,013	$447.8613	$1.80M
Sale	Common Stock	6,723	$448.8474	$3.02M
Sale	Common Stock	2,586	$449.8883	$1.16M
Sale	Common Stock	3,338	$450.9435	$1.51M
Sale	Common Stock	4,418	$451.9576	$2.00M
Sale	Common Stock	1,204	$453.1214	$546K
Sale	Common Stock	1,980	$453.8275	$899K
Sale	Common Stock	3,269	$454.9207	$1.49M
Sale	Common Stock	2,898	$455.8879	$1.32M
Sale	Common Stock	3,396	$456.9729	$1.55M
Sale	Common Stock	4,574	$457.9988	$2.09M
Sale	Common Stock	3,837	$459.0178	$1.76M

Holdings After Transaction: Common Stock — 1,418,661 shares (Indirect, By Alba Trust)

Footnotes (1)

1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $429.1100 to $430.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $430.1100 to $430.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $432.1800 to $433.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $433.2300 to $433.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $434.2800 to $435.2500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $435.3200 to $436.3100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $436.3300 to $437.3100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $437.3300 to $438.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $438.3300 to $439.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $439.3600 to $440.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $440.3600 to $441.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $441.3600 to $442.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $442.3600 to $443.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $443.3600 to $444.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $444.3600 to $445.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $445.3600 to $446.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $446.3600 to $447.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $447.3600 to $448.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $448.3600 to $449.3300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $449.4200 to $450.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $450.4600 to $451.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $451.4600 to $452.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $452.4600 to $453.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $453.4900 to $454.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $454.5000 to $455.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $455.5000 to $456.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $456.5000 to $457.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $457.5100 to $458.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $458.5100 to $459.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 136,974 shares Remaining holdings: 1,418,661 shares Lowest sale price range: $429.11–$430.07 +3 more

6 metrics

Shares sold 136,974 shares Total common stock sold on July 1, 2026

Remaining holdings 1,418,661 shares Indirectly owned through Alba 2003 Living Trust after sales

Lowest sale price range $429.11–$430.07 Weighted-average price range disclosed in one transaction footnote

Highest sale price range $458.51–$459.44 Weighted-average price range disclosed in another footnote

Sale count 29 transactions Number of open-market sale entries coded “S”

Net direction net sale of 136,974 shares Transaction summary netBuySellShares and netBuySellDirection

Key Terms

Rule 10b5-1 trading plan, weighted average price, beneficial ownership, pecuniary interest

4 terms

Rule 10b5-1 trading plan regulatory

"occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficial ownership regulatory

"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 09:27 PM Accepted by SEC EDGAR 07/06/2026 - 09:27 PM Learn about SEC filing dates

FAQ

What did Astera Labs (ALAB) insider Manuel Alba report in this Form 4?

Manuel Alba reported that Alba 2003 Living Trust, with which he is associated, sold 136,974 shares of Astera Labs common stock on July 1, 2026 in multiple open-market transactions at weighted-average prices within specified ranges.

How many Astera Labs (ALAB) shares were sold and at what prices?

The filing shows total sales of 136,974 common shares of Astera Labs. Transactions occurred at weighted-average prices, with disclosed ranges from $429.11 to $459.44 per share across multiple trades executed that day.

How many Astera Labs (ALAB) shares remain held after the reported sales?

After the reported transactions, the Form 4 states that 1,418,661 shares of Astera Labs common stock remain indirectly owned through the Alba 2003 Living Trust, as of the end of the trading day on July 1, 2026.

Were the Astera Labs (ALAB) insider sales made under a Rule 10b5-1 plan?

Yes. A footnote explains that these sales occurred automatically under a Rule 10b5-1 trading plan adopted on May 29, 2025, indicating the transactions were pre-scheduled rather than discretionary trades based on short-term market developments.

Who actually owns the Astera Labs (ALAB) shares reported in this Form 4?

The shares are held by the Alba 2003 Living Trust, for which Manuel Alba-Marquez and his spouse are co-trustees. The filing states that Manuel Alba disclaims beneficial ownership except to the extent of any pecuniary interest in these securities.

What type of transactions were reported for Astera Labs (ALAB) in this Form 4?

All reported transactions are open-market sales of Astera Labs common stock, coded “S” on Form 4. The transaction summary shows 29 separate sale entries, totaling 136,974 shares, with no option exercises, gifts, or tax-withholding entries reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALBA MANUEL

(Last) (First) (Middle)

C/O ASTERA LABS, INC.

2345 NORTH FIRST STREET

(Street)

SAN JOSE CALIFORNIA 95131

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S(1)		5,837	D	$429.578(2)	1,418,661	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		30,141	D	$430.7907(4)	1,388,520	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		3,485	D	$432.7916(5)	1,385,035	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		1,574	D	$433.4284(6)	1,383,461	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		2,279	D	$434.7826(7)	1,381,182	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		2,122	D	$435.7564(8)	1,379,060	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		3,655	D	$436.8206(9)	1,375,405	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		2,129	D	$437.9323(10)	1,373,276	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		2,955	D	$438.7869(11)	1,370,321	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,332	D	$440.0528(12)	1,365,989	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		6,904	D	$440.8574(13)	1,359,085	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,468	D	$441.7946(14)	1,354,617	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,980	D	$442.8711(15)	1,349,637	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		5,437	D	$443.8246(16)	1,344,200	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		6,048	D	$444.9077(17)	1,338,152	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,310	D	$445.8516(18)	1,333,842	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,082	D	$446.9137(19)	1,329,760	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,013	D	$447.8613(20)	1,325,747	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		6,723	D	$448.8474(21)	1,319,024	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		2,586	D	$449.8883(22)	1,316,438	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		3,338	D	$450.9435(23)	1,313,100	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,418	D	$451.9576(24)	1,308,682	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		1,204	D	$453.1214(25)	1,307,478	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		1,980	D	$453.8275(26)	1,305,498	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		3,269	D	$454.9207(27)	1,302,229	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		2,898	D	$455.8879(28)	1,299,331	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		3,396	D	$456.9729(29)	1,295,935	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		4,574	D	$457.9988(30)	1,291,361	I	By Alba Trust(3)
Common Stock	07/01/2026		S(1)		3,837	D	$459.0178(31)	1,287,524	I	By Alba Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $429.1100 to $430.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $430.1100 to $430.9300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $432.1800 to $433.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $433.2300 to $433.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $434.2800 to $435.2500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $435.3200 to $436.3100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $436.3300 to $437.3100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $437.3300 to $438.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $438.3300 to $439.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $439.3600 to $440.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

13. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $440.3600 to $441.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

14. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $441.3600 to $442.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $442.3600 to $443.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

16. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $443.3600 to $444.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $444.3600 to $445.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

18. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $445.3600 to $446.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

19. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $446.3600 to $447.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

20. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $447.3600 to $448.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

21. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $448.3600 to $449.3300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

22. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $449.4200 to $450.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

23. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $450.4600 to $451.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

24. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $451.4600 to $452.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

25. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $452.4600 to $453.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

26. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $453.4900 to $454.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

27. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $454.5000 to $455.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

28. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $455.5000 to $456.4700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

29. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $456.5000 to $457.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

30. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $457.5100 to $458.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

31. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $458.5100 to $459.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

This Form 4 is being filed in three parts due to the limitations of the U.S. Securities and Exchange Commission EDGAR filing system. Part 1 of 3.

	/s/ Philip Mazzara, Attorney-in-Fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)